))
04: Off-Label Drug Use, Lawsuits and Flawed Diet Culture
Manage episode 404548284 series 3554923
Content provided by Marcelle Pick, OB/GYN NP, Marcelle Pick, and OB/GYN NP. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Marcelle Pick, OB/GYN NP, Marcelle Pick, and OB/GYN NP or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
**Click Here to join the 21 Day Quick Start and jump start your weight loss journey!**
In this episode, Marcelle navigates through the craze, the science, and the societal impact of these medications, armed with insights from a Pew Research survey on American perceptions and the broader conversation on weight management. With a critical eye, she examines the dual role of GLP-1 agonists in regulating blood sugar and suppressing appetite, their initial use for diabetes, and the recent shift towards treating obesity – sparking shortages and ethical debates.
In this discussion, Marcelle addresses the widespread skepticism and lawsuits arising from adverse effects, such as gastrointestinal issues and psychiatric problems, tied to these drugs. He challenges the narrative of weight loss being a simple matter of willpower, advocating instead for a holistic approach that considers diet, exercise, stress, and genetics.
This episode is not just about questioning the efficacy and safety of weight loss medications. It's about unraveling the multidimensional aspects of weight management, exploring functional medicine perspectives, and uncovering the real stories behind the headlines. Whether you're curious about the science, concerned about the ethical implications, or seeking alternatives for weight management, this podcast offers a comprehensive look at what it really means to tackle obesity in today's world.
**Click Here to join the 21 Day Quick Start and jump start your weight loss journey!**
13 episodes
Share
